Deuterated Compounds for Restoring Mutant P53 Function
Copyright © Targeted News Service 2024
2024-04-23
ALEXANDRIA, Virginia, April 24 -- PMV PHARMACEUTICALS, INC., Princeton, New Jersey has been assigned a patent (No. US 11963953 B2, initially filed Jan. 26, 2023) developed by Binh Vu, North Caldwell, New Jersey, for "Deuterated compounds for restoring mutant p53 function." . . .